TY  - GEN
AU  - Cohen,Alexa
AU  - Spektor,Tanya M
AU  - Stampleman,Laura
AU  - Bessudo,Alberto
AU  - Rosen,Peter J
AU  - Klein,Leonard M
AU  - Woliver,Thomas
AU  - Flam,Marshall
AU  - Eshaghian,Shahrooz
AU  - Nassir,Youram
AU  - Maluso,Tina
AU  - Swift,Regina A
AU  - Vescio,Robert
AU  - Berenson,James R
TI  - Safety and efficacy of pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed or refractory multiple myeloma
SN  - 1365-2141
PY  - 2018///0222
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Dexamethasone
KW  - administration & dosage
KW  - Doxorubicin
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Polyethylene Glycols
KW  - Recurrence
KW  - Retreatment
KW  - Survival Analysis
KW  - Thalidomide
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/bjh.14992
ER  -